Real-world evidence from the first online healthcare analytics platform—Livingstone. Validation of its descriptive epidemiology module

Incidence and prevalence are key epidemiological determinants characterizing the quantum of a disease. We compared incidence and prevalence estimates derived automatically from the first ever online, essentially real-time, healthcare analytics platform—Livingstone—against findings from comparable peer-reviewed studies in order to validate the descriptive epidemiology module. The source of routine NHS data for Livingstone was the Clinical Practice Research Datalink (CPRD). After applying a general search strategy looking for any disease or condition, 76 relevant studies were first retrieved, of which 10 met pre-specified inclusion and exclusion criteria. Findings reported in these studies were compared with estimates produced automatically by Livingstone. The published reports described elements of the epidemiology of 14 diseases or conditions. Lin’s concordance correlation coefficient (CCC) was used to evaluate the concordance between findings from Livingstone and those detailed in the published studies. The concordance of incidence values in the final year reported by each study versus Livingstone was 0.96 (95% CI: 0.89–0.98), whilst for all annual incidence values the concordance was 0.93 (0.91–0.94). For prevalence, concordance for the final annual prevalence reported in each study versus Livingstone was 1.00 (0.99–1.00) and for all reported annual prevalence values, the concordance was 0.93 (0.90–0.95). The concordance between Livingstone and the latest published findings was near perfect for prevalence and substantial for incidence. For the first time, it is now possible to automatically generate reliable descriptive epidemiology from routine health records, and in near-real time. Livingstone provides the first mechanism to rapidly generate standardised, descriptive epidemiology for all clinical events from real world data.

[1]  M. Rutter,et al.  Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study , 2022, PLoS medicine.

[2]  Derek G Cook,et al.  Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data , 2021, PloS one.

[3]  W. O. Pickrell,et al.  Prevalence, healthcare resource utilization and mortality of Lennox-Gastaut syndrome: retrospective linkage cohort study , 2021, Seizure.

[4]  G. Plant,et al.  Trends in Optic Neuritis Incidence and Prevalence in the UK and Association With Systemic and Neurologic Disease. , 2020, JAMA neurology.

[5]  P. Tiňo,et al.  Data extraction for epidemiological research (DExtER): a novel tool for automated clinical epidemiology studies , 2020, European Journal of Epidemiology.

[6]  Jenny C. Warner,et al.  A descriptive epidemiological study of the incidence of newly diagnosed Lyme disease cases in a UK primary care cohort, 1998–2016 , 2020, BMC Infectious Diseases.

[7]  C. Coupland,et al.  Trends in Incidence and Prevalence of Osteoarthritis in the United Kingdom: Findings from the Clinical Practice Research Datalink (CPRD). , 2020, Osteoarthritis and cartilage.

[8]  S. Birring,et al.  Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity? , 2020, Current medical research and opinion.

[9]  Darren Lunn,et al.  Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum , 2019, International journal of epidemiology.

[10]  Jeremy A Rassen,et al.  Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases , 2018, Clinical epidemiology.

[11]  M. Grainge,et al.  The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink , 2018, Clinical Rheumatology.

[12]  T. Maher,et al.  Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK , 2018, Advances in Therapy.

[13]  G. Schernthaner,et al.  Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013 , 2017, Diabetic medicine : a journal of the British Diabetic Association.

[14]  P. Scanlon The English National Screening Programme for diabetic retinopathy 2003–2016 , 2017, Acta Diabetologica.

[15]  K. Bhaskaran,et al.  Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014 , 2017, BMJ Open.

[16]  D. Reeves,et al.  Incidence, prevalence and mortality of patients with psoriasis: a U.K. population‐based cohort study , 2016, The British journal of dermatology.

[17]  Jonathan V Sweedler,et al.  Writing a review. , 2014, Analytical chemistry.

[18]  Ed Zintel,et al.  Resources , 1998, IT Prof..

[19]  R. Neal PROJECT ADMINISTRATION , 2009 .

[20]  G. Mahon A Proposal for Strength-of-Agreement Criteria for Lin’s Concordance Correlation Coefficient , 2005 .